Rx100
RX100 FOR ACUTE RADIATION SYNDROME (ARS). Rx100 has shown efficacy for GI-ARS in both large and small animal models with survival as the endpoint. To date have completed quality manufacturing, pharmacology, and many of the IND-enabling toxicology predicates to human safety testing. Rx100 is in the development stages and has been largely funded through government grants and contracts. The development pathway continues to be guided through timely interactions with FDA.
Availability: In Development
Manufacturer |
| RxBio, Inc. |
Product Name |
| Rx100 |
Detection Category |
| Radiological/Nuclear |
Detection Method |
| Medical Countermeasure; |
Application |
| Personal Protective Equipment; |
Equipment Type |
| PPE |
Product Synopsis |
| RX100 FOR ACUTE RADIATION SYNDROME (ARS). Rx100 has shown efficacy for GI-ARS in both large and small animal models with survival as the endpoint. To date have completed quality manufacturing, pharmacology, and many of the IND-enabling toxicology predicates to human safety testing. Rx100 is in the development stages and has been largely funded through government grants and contracts. The development pathway continues to be guided through timely interactions with FDA. |
Availability |
| In Development |
Technology Readiness Level (TRL) |
| 6 |
User Feedback Sources |
| Indifferent/No user feedback |
Weight |
| <1 lb. |
Power Requirements |
| None |
Transportability |
| Pocket Size |
Operating Time |
| Immediate post-exposure use |
Training Required |
| <1 hour training |
Manuals Available |
| Yes |